Krka is a generic pharmaceutical company engaged in the development, production, marketing, and sales of prescription pharmaceuticals, non-prescription products, and animal health products. Self-described as one of the leading companies in its field.

Krka

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

KRK

BIZ:KRKA

Krka

Last Close

602.00

22/11 14:46

Market Cap

18.80B

Beta: -

Volume Today

13

Avg: -

Analysis Not Available